Characterization in Inhibitory Effectiveness of Carbamazepine in Voltage-Gated Na+ and Erg-Mediated K+ Currents in a Mouse Neural Crest-Derived (Neuro-2a) Cell Line
Open Access
- 17 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7892
Abstract
Carbamazepine (CBZ, Tegretol®) is an anticonvulsant used in the treatment of epilepsy and neuropathic pain; however, several unwanted effects of this drug have been noticed. Therefore, the regulatory actions of CBZ on ionic currents in electrically excitable cells need to be reappraised, although its efficacy in suppressing voltage-gated Na+ current (INa) has been disclosed. This study was undertaken to explore the modifications produced by CBZ on ionic currents (e.g., INa and erg-mediated K+ current [IK(erg)]) measured from Neuro-2a (N2a) cells. In these cells, we found that this drug differentially suppressed the peak (transient, INa(T)) and sustained (late, INa(L)) components of INa in a concentration-dependent manner with effective IC50 of 56 and 18 μM, respectively. The overall current–voltage relationship of INa(T) with or without the addition of CBZ remained unchanged; however, the strength (i.e., ∆area) in the window component of INa (INa(W)) evoked by the short ascending ramp pulse (Vramp) was overly lessened in the CBZ presence. Tefluthrin (Tef), a synthetic pyrethroid, known to stimulate INa, augmented the strength of the voltage-dependent hysteresis (Hys(V)) of persistent INa (INa(P)) in response to the isosceles-triangular Vramp; moreover, further application of CBZ attenuated Tef-mediated accentuation of INa(P)’s Hys(V). With a two-step voltage protocol, the recovery of INa(T) inactivation seen in Neuro-2a cells became progressively slowed by adding CBZ; however, the cumulative inhibition of INa(T) evoked by pulse train stimulation was enhanced during exposure to this drug. Neuro-2a-cell exposure to CBZ (100 μM), the magnitude of erg-mediated K+ current measured throughout the entire voltage-clamp steps applied was mildly inhibited. The docking results regarding the interaction of CBZ and voltage-gate Na+ (NaV) channel predicted the ability of CBZ to bind to some amino-acid residues in NaV due to the existence of a hydrogen bond or hydrophobic contact. It is conceivable from the current investigations that the INa (INa(T), INa(L), INa(W), and INa(P)) residing in Neuro-2a cells are susceptible to being suppressed by CBZ, and that its block on INa(L) is larger than that on INa(T). Collectively, the magnitude and gating of NaV channels produced by the CBZ presence might have an impact on its anticonvulsant and analgesic effects occurring in vivo.Keywords
Funding Information
- National Cheng Kung University Hospital (NCKUH-11102050, NCKUH-11102029, MOST-110-2320-B-006-028, 110-2314-B-006-056)
- Ministry of Science and Technology (NCKUH-11102050, NCKUH-11102029, MOST-110-2320-B-006-028, 110-2314-B-006-056)
This publication has 81 references indexed in Scilit:
- Mechanism and molecular basis for the sodium channel subtype specificity of µ‐conopeptide CnIIICBritish Journal of Pharmacology, 2012
- Left-Shifted Nav Channels in Injured Bilayer: Primary Targets for Neuroprotective Nav Antagonists?Frontiers in Pharmacology, 2012
- Inhibition of Navβ4 Peptide-Mediated Resurgent Sodium Currents in Nav1.7 Channels by Carbamazepine, Riluzole, and AnandamideMolecular Pharmacology, 2011
- Actions of tefluthrin on rat Nav1.7 voltage-gated sodium channels expressed in Xenopus oocytesPesticide Biochemistry and Physiology, 2011
- Pacemaking in Dopaminergic Ventral Tegmental Area Neurons: Depolarizing Drive from Background and Voltage-Dependent Sodium ConductancesThe Journal of Neuroscience, 2010
- Analytical studies of rapidly inactivating and noninactivating sodium currents in differentiated NG108-15 neuronal cellsJournal of Theoretical Biology, 2009
- Background sodium current underlying respiratory rhythm regularityEuropean Journal of Neuroscience, 2008
- Carbamazepine-Induced Transient Auditory Pitch-Perception DeficitPediatric Neurology, 2006
- Pharmacokinetics of carbamazepine derived from a new tablet formulationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1995
- Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responsesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991